Notice2025-10621
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 11, 2025
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 111 (Wednesday, June 11, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 111 (Wednesday, June 11, 2025)]
[Notices]
[Pages 24629-24630]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-10621]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-25-1442]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``NHSN Becton Dickinson BACTEC(TM) Blood
Culture Media Bottles Shortage Impact Questionnaire'' to the Office of
Management and Budget (OMB) for review and approval. CDC previously
published a notice on October 1, 2024, to obtain comments from the
public and affected agencies. CDC received no comments related to the
previous notice. This notice serves to allow an additional 30 days for
public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
National Healthcare Safety Network (NHSN) Becton Dickinson BACTECTM
Blood Culture Media Bottles Shortage Impact Questionnaire (OMB Control
No. 0920-1442, Exp. 02/28/2028)--Revision--National Center for Emerging
and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The Division of Healthcare Quality Promotion (DHQP), National
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention (CDC) collects data from healthcare
facilities in the National Healthcare Safety Network (NHSN) under OMB
Control Number 0920-0666. NHSN provides facilities, health departments,
states, regions, and the nation with data necessary to identify problem
areas, measure the progress of prevention efforts, and ultimately
eliminate healthcare-associated infections (HAIs) nationwide. NHSN also
allows healthcare facilities to track blood safety errors and various
HAI prevention practice methods such as healthcare personnel influenza
vaccine status and corresponding infection control adherence rates.
NHSN's data is used to aid in the tracking of HAIs and guide
infection prevention activities/practices that protect patients. The
Centers for Medicare and Medicaid Services (CMS) and other payers use
these data to determine incentives for performance at healthcare
facilities across the U.S. and surrounding territories, and members of
the public may use some protected data to inform their selection among
available providers. Each of these parties is dependent on the
completeness and accuracy of the data. CDC and CMS work closely and are
fully committed to ensuring complete and accurate reporting, which are
critical for protecting patients and guiding national, state, and local
prevention priorities.
The U.S. Food and Drug Administration (FDA) posted an announcement
regarding interruptions in the supply of Becton Dickinson (BD) BACTECTM
blood culture media bottles because of recent supplier issues. The
disruption in the supply is expected to impact patient diagnosis,
follow up patient management, and antimicrobial stewardship efforts.
The FDA and other entities recommend that facilities, laboratories, and
health care providers consider conservation strategies to prioritize
the use of blood culture media bottles, preserving the supply for
patients at highest risk. This information collection request was
initially approved under Emergency processing procedures on 9/27/2024
as OMB Control No. 0920-1442. This package is submitted as a Revision
to allow data collection to continue beyond the initial approval period
and
[[Page 24630]]
includes a new data collection instrument that will assess the impact
of the supply shortage on individual facilities and how CDC NHSN
bloodstream infection surveillance might be affected. Facilities
enrolled in the NHSN Patient Safety Component will be asked questions
regarding the impact of the Becton Dickinson (BD) BACTECTM blood
culture media bottles for their facility. The questions will be
collected electronically via the NHSN application.
CDC requests OMB approval for one year and a total of 2,334 annual
burden hours. There is no cost to respondents other than their time to
participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Infection Preventionist/ Blood Culture 3,500 1 20/60 1,167
Microbiologist. Bottle Shortage
Questionnaire
(Jul-Oct).
Infection Preventionist/ Blood Culture 3,500 1 20/60 1,167
Microbiologist. Bottle Shortage
Questionnaire
(Nov-Mar).
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2025-10621 Filed 6-10-25; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on June 11, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.